CORFLO Safety PEG Kit Recall by Avanos Medical
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Avanos Medical is recalling 72 CORFLO Safety PEG Kits with ENFit Connector due to inclusion of lidocaine hydrochloride injection subject to supplier quality issues.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 27, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Avanos Medical, Inc. initiated a recall of certain CORFLO Safety PEG Kits because lidocaine hydrochloride injection, the subject of a supplier recall for quality issues, was included in the sterile kits.
Which Products Are Affected
Product Name: CORFLO* Safety PEG Kit with ENFit¿ Connector Model/Catalog Number: 50-5320 UDI-DI: 10350770007516 Lot Numbers: 30365231, 30371022, 30373824, 30378385, 30383807, 30385321 Quantity: 72 kits Distribution: US Nationwide distribution Recall Number: Z-2338-2026
What You Should Do
Consumers should follow guidance from the recalling firm regarding the affected kits.
Why This Matters
The Class II recall involves 72 kits distributed nationwide that contained a component subject to quality issues.
Source
FDA recall Z-2338-2026, Avanos Medical, Inc., Alpharetta, GA. https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (859 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to July 27, 2026.
Frequently Asked Questions
Common questions about this FDA recall.